Rahul Singh Kathayat

Dr. Rahul Singh Kathayat

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JOJerzy Osipiuk
Jerzy Osipiuk
SASaara-Anne Azizi
Saara-Anne Azizi
SDSteve Dvorkin
Steve Dvorkin
MEMichael Endres
Michael Endres
RJRobert Jedrzejczak
Robert Jedrzejczak
AJAndrzej Joachimiak
Andrzej Joachimiak
The pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to expand. Papain-like protease (PLpro) is one of two SARS-CoV-2 proteases potentially targetable with antivirals. PLpro is an attractive target because it plays an essential role in cleavage and maturation of viral polyproteins, assembly of the replicase-transcriptase complex, and disruption of host responses. We report a substantive body of structural, biochemical, and virus replication studies that identify several inhibitors of the SARS-CoV-2 enzyme. We determined the high resolution structure of wild-type PLpro, the active site C111S mutant, and their complexes with inhibitors. This collection of structures details inhibitors recognition and interactions providing fundamental molecular and mechanistic insight into PLpro. All compounds inhibit the peptidase activity of PLpro in vitro, some block SARS-CoV-2 replication in cell culture assays. These findings will accelerate structure-based drug design efforts targeting PLpro to identify high-affinity inhibitors of clinical value.

20 July 2021 in Science
Verified
Journal Article
Open access
PDF file
NDNir Drayman
Nir Drayman
JDJennifer K. DeMarco
Jennifer K. DeMarco
KJKrysten A. Jones
Krysten A. Jones
SASaara-Anne Azizi
Saara-Anne Azizi
HFHeather M. Froggatt
Heather M. Froggatt
STSavas Tay
Savas Tay
Targeting the main protease of SARS-CoV-2: Inside host cells, the RNA genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is translated into two polyproteins that are cleaved to give the individual viral proteins. The main viral protease, known as Mpro or 3CLpro, plays a key role in these cleavages, making it an important drug target. Drayman et al . identified eight drugs that target 3CLpro from a library of 1900 clinically safe drugs. Because of the challenge of working with SARS-CoV-2, they started by screening for drugs that inhibit the replication of a human coronavirus that causes the common cold. They then evaluated the top hits for inhibiting SARS-CoV-2 replication and for inhibiting 3CLpro. Masitinib, a broad antiviral, inhibited the main proteases of coronaviruses and picornaviruses and was effective in reducing SARS-CoV-2 replication in mice. —VV

18 November 2019 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
YCYang Cao
Yang Cao
TQTian Qiu
Tian Qiu
RKRahul Singh Kathayat
Rahul Singh Kathayat
SASaara-Anne Azizi
Saara-Anne Azizi
ATAnneke K. Thorne
Anneke K. Thorne
BDBryan C. Dickinson
Bryan C. Dickinson

23 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
RKRahul Singh Kathayat
Rahul Singh Kathayat
YCYang Cao
Yang Cao
PEPablo D. Elvira
Pablo D. Elvira
PSPatrick A. Sandoz
Patrick A. Sandoz
MZMaría-Eugenia Zaballa
María-Eugenia Zaballa
BDBryan C. Dickinson
Bryan C. Dickinson
The reversible modification of cysteine residues by thioester formation with palmitate (S-palmitoylation) is an abundant lipid post-translational modification (PTM) in mammalian systems. S-palmitoylation has been observed on mitochondrial proteins, providing an intriguing potential connection between metabolic lipids and mitochondrial regulation. However, it is unknown whether and/or how mitochondrial S-palmitoylation is regulated. Here we report the development of mitoDPPs, targeted fluorescent probes that measure the activity levels of “erasers” of S-palmitoylation, acyl-protein thioesterases (APTs), within mitochondria of live cells. Using mitoDPPs, we discover active S-depalmitoylation in mitochondria, in part mediated by APT1, an S-depalmitoylase previously thought to reside in the cytosol and on the Golgi apparatus. We also find that perturbation of long-chain acyl-CoA cytoplasm and mitochondrial regulatory proteins, respectively, results in selective responses from cytosolic and mitochondrial S-depalmitoylases. Altogether, this work reveals that mitochondrial S-palmitoylation is actively regulated by “eraser” enzymes that respond to alterations in mitochondrial lipid homeostasis.

19 December 2016 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
RKRahul Singh Kathayat
Rahul Singh Kathayat
PEPablo D Elvira
Pablo D Elvira
BDBryan C Dickinson
Bryan C Dickinson
The development of small-molecule fluorescent probes through addition of a lipidated cysteine residue next to a caged fluorophore enables detection of endogenous cysteine depalmitoylation by acyl–protein thioesterases in vitro and in live cells. Hundreds of human proteins are modified by reversible palmitoylation of cysteine residues (S-palmitoylation), but the regulation of depalmitoylation is poorly understood. Here, we develop 'depalmitoylation probes' (DPPs), small-molecule fluorophores, to monitor the endogenous activity levels of 'erasers' of S-palmitoylation, acylprotein thioesterases (APTs). Live-cell analysis with DPPs reveals rapid growth-factor-mediated inhibition of the depalmitoylation activity of APTs, exposing a novel regulatory mechanism of dynamic lipid signaling.

26 July 2021 in ACS Chemical Biology
Verified
Journal Article
Closed access
SASaara-Anne Azizi
Saara-Anne Azizi
TLTong Lan
Tong Lan
CDClémence Delalande
Clémence Delalande
RKRahul Singh Kathayat
Rahul Singh Kathayat
FMFernando Banales Mejia
Fernando Banales Mejia
BDBryan C. Dickinson
Bryan C. Dickinson